Structures by: Mühlgassner G.
Total: 27
9-Nitro-6-(alpha-picolylamino)-7,12-dihydroindolo[3,2-d][1]benzazepine
C22H17N5O2
Journal of medicinal chemistry (2007) 50, 25 6343-6355
a=10.8951(10)Å b=20.050(2)Å c=8.6412(9)Å
α=90.00° β=90.160(4)° γ=90.00°
(hapto^6^-p-Cymene)[9-pyridin-kappaN-2-yl-(E)-methylidene)amino-kappaN-7,12- dihydroindolo[3,2-d][1]benzazepin-6(5H)-one]chloroosmium(II) chloride acetone solvate
C35H36Cl2N4O2Os
Journal of medicinal chemistry (2007) 50, 25 6343-6355
a=9.876(2)Å b=9.6263(19)Å c=17.460(4)Å
α=90.00° β=104.32(3)° γ=90.00°
(hapto^6^-p-Cymene){9-nitro-6-[(alpha-picolyl-kappaN)imino-kappaN]-7,12- dihydroindolo[3,2-d][1]benzazepine}chlororuthenium(II) chloride diethanol solvate
C36H43Cl2N5O4Ru
Journal of medicinal chemistry (2007) 50, 25 6343-6355
a=12.2485(4)Å b=12.6418(5)Å c=14.3132(5)Å
α=95.421(2)° β=108.122(2)° γ=118.054(2)°
(hapto^6^-p-Cymene){9-nitro-6-[(alpha-picolyl-kappaN)imino-kappaN]-7,12- dihydroindolo[3,2-d][1]benzazepine}chlororuthenium(II) chloride diethanol water solvate
C36H45Cl2N5O5Ru
Journal of medicinal chemistry (2007) 50, 25 6343-6355
a=10.771(2)Å b=25.040(5)Å c=13.238(3)Å
α=90.00° β=91.84(3)° γ=90.00°
(hapto^6^-p-Cymene){9-bromo-6-[(alpha-picolyl-kappaN)imino-kappaN]-7,12- dihydroindolo[3,2-d][1]benzazepine}chloroosmium(II) chloride ethanol water solvate
C130H133Br4Cl8N16O3.5Os4
Journal of medicinal chemistry (2007) 50, 25 6343-6355
a=13.8319(5)Å b=14.1376(5)Å c=18.3912(6)Å
α=98.511(2)° β=107.338(2)° γ=102.012(2)°
(hapto^6^-p-Cymene){9-nitro-6-[(alpha-picolyl-kappaN)imino-kappaN]-7,12- dihydroindolo[3,2-d][1]benzazepine}chloroosmium(II) chloride ethanol water solvate
C35.9H42.95Cl2N5O4.08Os
Journal of medicinal chemistry (2007) 50, 25 6343-6355
a=12.2836(4)Å b=12.6756(4)Å c=14.2592(6)Å
α=95.491(2)° β=107.998(2)° γ=118.072(2)°
(hapto^6^-p-Cymene){6-[(alpha-picolyl-kappaN)imino-kappaN]-7,12- dihydroindolo[3,2-d][1]benzazepine}chloroosmium(II) chloride water solvate
C32H32.5Cl2N4O0.25Os
Journal of medicinal chemistry (2007) 50, 25 6343-6355
a=13.9580(7)Å b=14.0949(7)Å c=18.3531(9)Å
α=96.749(3)° β=108.022(3)° γ=102.050(3)°
(hapto^6^-p-Cymene)[9-pyridin-kappaN-2-yl-(E)-methylidene)amino-kappaN-7,12- dihydroindolo[3,2-d][1]benzazepin-6(5H)-one]chlororuthenium(II) chloride acetone solvate
C35H36Cl2N4O2Ru
Journal of medicinal chemistry (2007) 50, 25 6343-6355
a=9.872(2)Å b=9.6208(19)Å c=17.434(4)Å
α=90.00° β=104.05(3)° γ=90.00°
{(hapto^6^-p-cymene)[N-(2-chloro-5,11-dihydroindolo[3,2-c]quinolin-6- ylidene)kappaN'-(1-kappaN-pyridin-2-yl-methylidene)]azine chlorido- ruthenium(II)} chloride
C31H28Cl2N5Ru,Cl
Organometallics (2011) 30, 2 273-283
a=26.5354(10)Å b=26.5354(10)Å c=9.0872(4)Å
α=90.00° β=90.00° γ=90.00°
{(hapto^6^-p-cymene)[N-(2-chloro-5,11-dihydroindolo[3,2-c]quinolin-6- ylidene)kappaN'-(1-kappaN-pyridin-2-yl-ethylidene)]azine chlorido- ruthenium(II)} chloride ethanol solvate
C32H30Cl2N5Ru,C2H6O,Cl
Organometallics (2011) 30, 2 273-283
a=10.7350(4)Å b=12.0515(4)Å c=25.1678(9)Å
α=90.00° β=94.293(2)° γ=90.00°
{(hapto^6^-p-cymene)[N-(2-methyl-5,11-dihydroindolo[3,2-c]quinolin-6- ylidene)kappaN'-(1-kappaN-pyridin-2-yl-ethylidene)]azine chlorido- osmium(II)} chloride hydrate
C33H33ClN5Os,0.5(O2),Cl
Organometallics (2011) 30, 2 273-283
a=11.690(2)Å b=21.276(4)Å c=25.898(4)Å
α=90.00° β=102.712(9)° γ=90.00°
{(hapto^6^-p-cymene)[N-(2-chloro-5,11-dihydroindolo[3,2-c]quinolin-6- ylidene)kappaN'-(1-kappaN-pyridin-2-yl-methylidene)]azine chlorido- osmium(II)} chloride diethyl ether water solvate
4(C31H28Cl2N5Os),2(C2H5O2),O3,4(Cl)
Organometallics (2011) 30, 2 273-283
a=17.2834(5)Å b=14.0348(5)Å c=29.4680(11)Å
α=90.00° β=106.416(4)° γ=90.00°
{(hapto^6^-p-cymene)[N-(5,11-dihydroindolo[3,2-c]quinolin-6- ylidene)kappaN'-(1-kappaN-pyridin-2-yl-ethylidene)]azine chlorido- ruthenium(II)} chloride hydrate
C32H31ClN5Ru,0.2(O4),Cl,0.9(O)
Organometallics (2011) 30, 2 273-283
a=10.4899(3)Å b=11.8881(3)Å c=25.1390(8)Å
α=90.00° β=95.195(2)° γ=90.00°
{(hapto^6^-p-cymene)[N-(2-methyl-5,11-dihydroindolo[3,2-c]quinolin-6- ylidene)kappaN'-(1-kappaN-pyridin-2-yl-methylidene)]azine chlorido- ruthenium(II)} chloride
C34H36.4Cl2N5O0.7Ru
Organometallics (2011) 30, 2 273-283
a=10.6834(11)Å b=12.0598(12)Å c=25.482(3)Å
α=90.00° β=93.080(7)° γ=90.00°
N-(9-Bromo-7,12-dihydroindolo-[3,2-d][1]benzazepin-6(5H)-yliden)-N'- (1-pyridin-2-yl-methylidene)-azine dimethanol solvate
C22H16BrN5,2(CH4O)
Inorganic Chemistry (2010) 49, 302-311
a=12.3094(5)Å b=11.1450(4)Å c=17.0199(7)Å
α=90.00° β=97.995(2)° γ=90.00°
9-Bromo-6-N-(2-N',N'-dimethylaminoethylamino)-7,12-dihydroindolo- [3,2-d][1]benzazepine monoethanol solvate
C20H21BrN4,C2H6O
Inorganic Chemistry (2010) 49, 302-311
a=10.978(2)Å b=9.193(2)Å c=21.116(4)Å
α=90.00° β=94.93(3)° γ=90.00°
N-(9-Bromo-7,12-dihydroindolo-[3,2-d][1]benzazepin-6-yliden)-N'- (1-pyridin-2-yl-methyliden)-azin-5-ide-dichlorido-copper(II) methanol solvate
4(C22H17.5BrCl2CuN5),O3
Inorganic Chemistry (2010) 49, 302-311
a=12.7662(8)Å b=13.5586(8)Å c=13.1869(8)Å
α=90.00° β=105.691(4)° γ=90.00°
6-N-(2-N',N'-dimethylaminoethylenamino)-7,12-dihydroindolo- [3,2-d][1]benzazepino-dichlorido-copper(II)
C20H22Cl2CuN4
Inorganic Chemistry (2010) 49, 302-311
a=15.1349(9)Å b=7.6083(5)Å c=17.3917(11)Å
α=90.00° β=101.579(4)° γ=90.00°
9-Bromo-6-N-(2-N',N'-dimethylamino)-7,12-dihydroindolo[3,2-d][1] benzazepino-dichlorido-copper(II)
C20H21BrCl2CuN4
Inorganic Chemistry (2010) 49, 302-311
a=10.1511(5)Å b=10.8098(6)Å c=11.7944(9)Å
α=113.613(4)° β=93.568(4)° γ=115.547(3)°
N-(9-Bromo-7,12-dihydroindolo-[3,2-d][1]benzazepin-6-yliden)-N'- (1-pyridin-2-yl-ethyliden)-azin-5-ide-acetato-methanolo-copper(II) trimethanol solvate
C26H24BrCuN5O3,3(CH4O)
Inorganic Chemistry (2010) 49, 302-311
a=9.2218(3)Å b=12.6553(5)Å c=13.7218(6)Å
α=107.719(3)° β=90.188(2)° γ=98.000(2)°
(hapto^6^-p-cymene){5-bromo-3-(7-methoxymethyl-1H-benzimidazol-kappaN-2-yl)- pyrazolo-kappaN-[3,4-b]pyridin-1-ide}chlroridoruthenium(II)
C25H25BrClN5ORu
Inorganic Chemistry (2011) 50, 11715-11728
a=16.7948(13)Å b=12.4936(10)Å c=12.3028(8)Å
α=90.00° β=108.744(5)° γ=90.00°
5-bromo-3-methyl-1H-pyrazolo[3,4-b]pyridine
2(C7H6BrN3),H2O
Inorganic Chemistry (2011) 50, 11715-11728
a=7.0878(3)Å b=7.5561(3)Å c=16.5281(8)Å
α=98.267(3)° β=97.046(3)° γ=107.894(3)°
(hapto^6^-p-cymene){3-(1H-benzimidazol-kappaN-2-yl)-5-bromo- 1H-pyrazolo-kappaN-[3,4-b]pyridine}chloridoosmium(II) chloride
C23H22BrClN5Os,Cl
Inorganic Chemistry (2011) 50, 11715-11728
a=8.5092(10)Å b=19.402(3)Å c=14.497(3)Å
α=90.00° β=91.531(5)° γ=90.00°
(hapto^6^-p-cymene){3-(1H-benzimidazol-kappaN-2-yl)-5-bromo- 1H-pyrazolo-kappaN-[3,4-b]pyridine}chloridoosmium(II) chloride dimethanol dihydrate
C23H22BrClN5Os,2(CH4O),2(H2O),Cl
Inorganic Chemistry (2011) 50, 11715-11728
a=8.4014(8)Å b=13.1678(14)Å c=13.7997(16)Å
α=81.446(4)° β=81.191(5)° γ=76.887(5)°
(hapto^6^-p-cymene){3-(1H-benzimidazol-kappaN-2-yl)-1H-pyrazolo- kappaN-[3,4-b]pyridine}chloridoosmium(II) chloride tetrahydrate
C23H23ClN5Os,4(H2O),Cl
Inorganic Chemistry (2011) 50, 11715-11728
a=19.2075(13)Å b=7.7890(5)Å c=17.0807(11)Å
α=90.00° β=99.334(4)° γ=90.00°
(hapto^6^p-cymene){5-bromo-3-(7-methoxymethyl-1H-benzimidazol-kappaN-2-yl)- 1H-pyrazolo-kappaN-[3,4-b]pyridine}chloridoruthenium(II) chloride- (hapto^6^p-cymene){5-bromo-3-(7-methoxymethyl-1H-benzimidazol-kappaN-2-yl)- -pyrazolo-kappaN-[3,4-b]pyridin-1-ide}chloridoruthenium(II) methanol solvate
C25H26BrClN5ORu,C25H25BrClN5ORu,CH4O,Cl
Inorganic Chemistry (2011) 50, 11715-11728
a=9.9942(9)Å b=15.4370(13)Å c=17.8076(17)Å
α=104.380(5)° β=93.139(5)° γ=98.859(4)°
(hapto^6^p-cymene){5-bromo-3-(7-methoxymethyl-1H-benzimidazol-kappaN-2-yl)- 1H-pyrazolo-kappaN-[3,4-b]pyridine}chloridoosmium(II) chloride- (hapto^6^p-cymene){5-bromo-3-(7-methoxymethyl-1H-benzimidazol-kappaN-2-yl)- -pyrazolo-kappaN-[3,4-b]pyridin-1-ide}chloridoosmium(II) methanol water solvate
C25H26BrClN5OOs,C25H25BrClN5OOs,0.75(CH4O),O
Inorganic Chemistry (2011) 50, 11715-11728
a=10.0042(5)Å b=15.3936(8)Å c=17.8050(9)Å
α=104.233(2)° β=93.029(2)° γ=98.683(3)°